Celldex Therapeutics, Inc. Operating Lease, Liability, Current
Celldex Therapeutics, Inc. (CLDX) had Operating Lease, Liability, Current of $1.56 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $1.56M.
- 2026-03-31: Operating Lease, Liability, Current $1.47M.
- 2025-12-31: Operating Lease, Liability, Current $1.55M.
- 2025-09-30: Operating Lease, Liability, Current $1.55M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $1.56M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.55M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.55M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.54M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.50M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.45M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.38M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.59M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.64M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $1.61M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.55M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.53M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.49M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.45M 10-K · filed 2024-02-26 |
| 2022-09-30 | $1.44M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.43M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.80M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.75M 10-K · filed 2023-02-28 |
| 2021-09-30 | $1.37M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.33M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.37M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.33M 10-K · filed 2022-02-28 |
| 2020-09-30 | $1.26M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.32M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.68M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.94M 10-K · filed 2021-03-29 |
| 2019-09-30 | $2.25M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.54M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.63M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |